ALPS Advisors’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $488K | Buy |
868
+150
| +21% | +$96.2K | ﹤0.01% | 868 |
|
|
2025
Q4 | $486K | Buy |
718
+8
| +1% | +$5.45K | ﹤0.01% | 755 |
|
|
2025
Q3 | $454K | Sell |
710
-150
| -17% | -$91K | ﹤0.01% | 781 |
|
|
2025
Q2 | $461K | Buy |
860
+10
| +1% | +$4.78K | ﹤0.01% | 659 |
|
|
2025
Q1 | $357K | Buy |
+850
| New | +$369K | ﹤0.01% | 749 |
|
|
2024
Q3 | – | Sell |
-631
| Closed | -$307K | – | 1066 |
|
|
2024
Q2 | $307K | Sell |
631
-3
| -0.5% | -$1.51K | ﹤0.01% | 837 |
|
|
2024
Q1 | $342K | Sell |
634
-34
| -5% | -$18.6K | ﹤0.01% | 864 |
|
|
2023
Q4 | $371K | Sell |
668
-45
| -6% | -$21.1K | ﹤0.01% | 725 |
|
|
2023
Q3 | $312K | Buy |
713
+13
| +2% | +$6.48K | ﹤0.01% | 857 |
|
|
2023
Q2 | $352K | Buy |
700
+10
| +1% | +$4.79K | ﹤0.01% | 721 |
|
|
2023
Q1 | $345K | Buy |
+690
| New | +$330K | ﹤0.01% | 693 |
|
|
2022
Q3 | – | Sell |
-687
| Closed | -$241K | – | 1127 |
|
|
2022
Q2 | $241K | Sell |
687
-7
| -1% | -$2.85K | ﹤0.01% | 956 |
|
|
2022
Q1 | $380K | Buy |
694
+138
| +25% | +$72.6K | ﹤0.01% | 523 |
|
|
2021
Q4 | $366K | Buy |
556
+7
| +1% | +$4.39K | ﹤0.01% | 744 |
|
|
2021
Q3 | $341K | Sell |
549
-120
| -18% | -$80.6K | ﹤0.01% | 783 |
|
|
2021
Q2 | $423K | Hold |
669
| – | – | ﹤0.01% | 556 |
|
|
2021
Q1 | $327K | Sell |
669
-40
| -6% | -$20K | ﹤0.01% | 742 |
|
|
2020
Q4 | $354K | Sell |
709
-2,431
| -77% | -$1.09M | ﹤0.01% | 601 |
|
|
2020
Q3 | $1.23M | Sell |
3,140
-441
| -12% | -$163K | 0.02% | 311 |
|
|
2020
Q2 | $1.18M | Buy |
3,581
+360
| +11% | +$104K | 0.02% | 289 |
|
|
2020
Q1 | $781K | Sell |
3,221
-569
| -15% | -$148K | 0.01% | 330 |
|
|
2019
Q4 | $990K | Sell |
3,790
-156
| -4% | -$41.1K | 0.01% | 349 |
|
|
2019
Q3 | $1.07M | Buy |
3,946
+1,196
| +43% | +$333K | 0.01% | 287 |
|
|
2019
Q2 | $757K | Sell |
2,750
-828
| -23% | -$204K | 0.01% | 397 |
|
|
2019
Q1 | $800K | Sell |
3,578
-243
| -6% | -$50.2K | 0.01% | 381 |
|
|
2018
Q4 | $711K | Buy |
3,821
+16
| +0.4% | +$3.28K | 0.01% | 387 |
|
|
2018
Q3 | $950K | Buy |
+3,805
| New | +$924K | 0.01% | 421 |
|
|
2015
Q3 | – | Sell |
-6,964
| Closed | -$447K | – | 720 |
|
|
2015
Q2 | $447K | Buy |
6,964
+108
| +2% | +$7.48K | ﹤0.01% | 600 |
|
|
2015
Q1 | $530K | Buy |
+6,856
| New | +$534K | ﹤0.01% | 387 |
|
|
2014
Q1 | – | Sell |
-10,084
| Closed | -$576K | – | 637 |
|
|
2013
Q4 | $576K | Sell |
10,084
-532
| -5% | -$28K | 0.01% | 238 |
|
|
2013
Q3 | $529K | Buy |
10,616
+2,944
| +38% | +$141K | 0.01% | 182 |
|
|
2013
Q2 | $344K | Buy |
+7,672
| New | +$335K | ﹤0.01% | 142 |
|
Other funds holding IDXX
VCM
VPM
ALPS Advisors's IDXX Position: Q1 2026 in Review
ALPS Advisors increased its Idexx Laboratories (IDXX) stake by 21% in Q1 2026, buying an estimated $96.2K and bringing the position to 868 shares worth $488K. The position accounts for ﹤0.01% of the portfolio, ranked #868.
ALPS Advisors first reported a position in IDXX in Q2 2013 and has held it in 32 quarters since. The position peaked at $1.23M in Q3 2020. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.
- ALPS Advisors held 868 shares of Idexx Laboratories worth $488K as of Q1 2026.
- ALPS Advisors bought 150 Idexx Laboratories shares in Q1 2026, an estimated $96.2K.
- Idexx Laboratories made up ﹤0.01% of ALPS Advisors's portfolio in Q1 2026, its #868 holding.
- ALPS Advisors first reported a position in Idexx Laboratories in Q2 2013 and has held it in 32 quarters since.
- ALPS Advisors's Idexx Laboratories position peaked at $1.23M in Q3 2020.
- 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.
Based on ALPS Advisors's 13F filing for Q1 2026, filed 8 May 2026.